Review: Type 2 diabetes in Latin America and the Caribbean: Regional and country comparison on prevalence, trends, costs and expanded prevention

Exploring Early Combination Strategy in Latin American Patients With Newly Diagnosed Type 2 Diabetes: A Sub-analysis of the VERIFY Study 

“…The diverseness of baseline characteristics con rms that the VERIFY study protocol genuinely allowed enrollment of a globally heterogeneous population re ective of currently diagnosed individuals with diabetes. In Latin America as in other global regions outside Northern Europe [18], a deeper analysis of the glycemic data from the screening phase reverberates the challenges in accurate, early and timely diagnosis of T2DM based on glycemia as reported for Latin America [6,8]. Therefore, in this region where there is less-structured public healthcare infrastructure, socioeconomic inequality, and limited access to care, it is sensible that recommendations and procedures facilitate early diagnosis and intervention.…”

“…Diabetes imposes a high economic burden in Latin American countries, incurring a total cost of USD 70 billion annually and constituting up to 6-24% of the annual total expenditure of the national health budgets [2]. The heterogeneity in the economic vulnerabilities towards diabetes across the region [6] might be due to inequalities in the socioeconomic aspects among countries in the Latin American region [7]. Socioeconomic conditions in Latin America present several public health challenges for diabetes care, such as low disease awareness, inadequate diagnosis, treatment and preventive measures, and limited access to healthcare facilities [6,8,9].…”

“…The heterogeneity in the economic vulnerabilities towards diabetes across the region [6] might be due to inequalities in the socioeconomic aspects among countries in the Latin American region [7]. Socioeconomic conditions in Latin America present several public health challenges for diabetes care, such as low disease awareness, inadequate diagnosis, treatment and preventive measures, and limited access to healthcare facilities [6,8,9]. Diagnosis is often delayed as the prevalence of undiagnosed patients ranges from 10.3-50% in this region [10].…”

“…The onset of T2DM at a younger age can result in a greater lifetime exposure to the risk of developing complications, thereby plausibly contributing to the 43.5% of diabetes-related deaths in patients under the age of 60 years [2,4]. The high incidence of T2DM at a young age, especially among women of child-bearing potential, poses challenges related to fertility and gestational diabetes, which creates a risk cycle with childhood obesity and a long-term risk of adult obesity in the next generation [6].…”

Exploring early combination strategy in Latin American patients with newly diagnosed type 2 diabetes: a sub-analysis of the VERIFY study

“…Diabetes imposes a high economic burden in Latin American countries, incurring a total cost of USD 70 billion annually and constituting up to 6–24% of the annual total expenditure of the national health budgets [ 2 ]. The heterogeneity in the economic vulnerabilities towards diabetes across the region [ 5 ] might be due to inequalities in the socioeconomic aspects among countries in the Latin American region [ 6 ]. Socioeconomic conditions in Latin America present several public health challenges for diabetes care, such as low disease awareness; inadequate diagnosis; treatment, and preventive measures; and limited access to health care facilities [ 5 , 7 , 8 ].…”